淀粉样变心肌病对目前的心衰治疗多无反应,其中位生存期小于6个月,5年存活率小于10%。
Amyloid cardiomyopathy is largely unresponsive to current heart failure therapies and is associated with a median survival of less than 6 months and a 5-year survival of less than 10%.
淀粉样变心肌病对目前的心衰治疗多无反应,其中位生存期小于6个月,5年存活率小于10%。
Amyloid cardiomyopathy is largely unresponsive to current heart failure therapies and is associated with a median survival of less than 6 months and a 5-year survival of less than 10%.
应用推荐